Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-041338

Chief Development Officer sold 1,004 shares at $25.65 ($25,749)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Longpre Lara Chief Development Officer 2023-07-03 Sale −1,004 $25.65 $25,749 105,839 D
Open-market sales · 1,004 sh · avg $25.65 · $25,749
Loading xslF345X04/doc4.xml…